G
Greenwich LifeSciences, Inc.
GLSI · NASDAQ · Healthcare · 247M
Closing price
$16.53
+9.18% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
633.4×
Enterprise value / EBITDAEV/EBITDA
-11.2×
Free cash flow yieldFCF yield
-4.4%
Return on equityROE
-5480.5%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.